 | Up a level |
2022
Passaro, A., Leighl, N., Blackhall, F., Popat, S., Kerr, K., Ahn, M. J., Arcila, M. E., Arrieta, O., Planchard, D., de Marinis, F., Dingemans, A. M., Dziadziuszko, R., Faivre-Finn, C., Feldman, J., Felip, E., Curigliano, G., Herbst, R., Janne, P. A., John, T., Mitsudomi, T., Mok, T., Normanno, N., Paz-Ares, L., Ramalingam, S., Sequist, L., Vansteenkiste, J., Wistuba, I. I., Wolf, J., Wu, Y. L., Yang, S. R., Yang, J. C. H., Yatabe, Y., Pentheroudakis, G. and Peters, S. (2022). ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer. Ann. Oncol., 33 (5). S. 466 - 488. AMSTERDAM: ELSEVIER. ISSN 1569-8041
2021
Le Rhun, E., Guckenberger, M., Smits, M., Dummer, R., Bachelot, T., Sahm, F., Galldiks, N., de Azambuja, E., Berghoff, A. S., Metellus, P., Peters, S., Hong, Y-K, Winkler, F., Schadendorf, D., van den Bent, M., Seoane, J., Stahel, R., Minniti, G., Wesseling, P., Weller, M. and Preusser, M. (2021). EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours. Ann. Oncol., 32 (11). S. 1332 - 1348. AMSTERDAM: ELSEVIER. ISSN 1569-8041
Morgan, G., Tagliamento, M., Lambertini, M., Devnani, B., Westphalen, B., Dienstmann, R., Bozovic-Spasojevic, I, Calles, A., Criscitiello, C., Curioni, A., Garcia, A. M., Lamarca, A., Pilotto, S., Scheffler, M., Strijbos, M., Wong, R., de Azambuja, E. and Peters, S. (2021). Impact of COVID-19 on social media as perceived by the oncology community: results from a survey in collaboration with the European Society for Medical Oncology (ESMO) and the OncoAlert Network. ESMO Open, 6 (2). AMSTERDAM: ELSEVIER. ISSN 2059-7029
Spigel, D. R., Vicente, D., Ciuleanu, T. E., Gettinger, S., Peters, S., Horn, L., Audigier-Valette, C., Pardo Aranda, N., Juan-Vidal, O., Cheng, Y., Zhang, H., Shi, M., Luft, A., Wolf, J., Antonia, S., Nakagawa, K., Fairchild, J., Baudelet, C., Pandya, D., Doshi, P., Chang, H. and Reck, M. (2021). Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331. Ann. Oncol., 32 (5). S. 631 - 642. AMSTERDAM: ELSEVIER. ISSN 1569-8041
2018
Heger, E., Peters, S., Onyuro, M., Kuemmerle, T., Voigt, E., Di Cristanziano, V., Sierra, S., Huesgen, L., Kulartz, H., Kaiser, R., Wyen, C. and Knops, E. (2018). Longitudinal analysis of proviral HIV-DNA. J. Int. AIDS Soc., 21. CHICHESTER: JOHN WILEY & SONS LTD. ISSN 1758-2652
Peters, S., Trueck, C., Altmueller, J., Kayser, K., Mangold, E., Holzapfel, S., Adam, R., Thiele, H., Spier, I. and Aretz, S. (2018). Exome sequencing identified potential candidate genes for serrated polyposis syndrome. Eur. J. Hum. Genet., 26. S. 602 - 604. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5438
Reck, M., Vicente, D., Ciuleanu, T., Gettinger, S., Peters, S., Horn, L., Audigier-Valette, C., Pardo, N., Juan-Vidal, O., Cheng, Y., Zhang, H., Shi, M., Wolf, J., Antonia, S. J., Nakagawa, K., Selvaggi, G., Baudelet, C., Chang, H. and Spigel, D. R. (2018). Efficacy and safety of nivolumab (nivo) monotherapy versus chemotherapy (chemo) in recurrent small cell lung cancer (SCLC): Results from CheckMate 331. Ann. Oncol., 29. S. 43 - 44. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041
2014
Krug, K. B., Weber, C., Schwabe, H., Sinzig, N. -M., Wein, B., Mueller, D., Wegmann, K., Peters, S., Sendler, V., Ewen, K., Hellmich, M. and Maintz, D. (2014). Comparison of image quality using a X-ray stereotactical whole-body system and a direct flat-panel X-ray device in examinations of the pelvis and knee. Rofo-Fortschr. Gebiet Rontgenstrahlen Bildgeb. Verfahr., 186 (1). S. 67 - 77. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-9010
2013
Fritschi, L., Erren, T. C., Glass, D. C., Girschik, J., Thomson, A. K., Saunders, C., Boyle, T., El-Zaemey, S., Rogers, P., Peters, S., Slevin, T., D'Orsogna, A., de Vocht, F., Vermeulen, R. and Heyworth, J. S. (2013). The association between different night shiftwork factors and breast cancer: a case-control study. Br. J. Cancer, 109 (9). S. 2472 - 2481. LONDON: NATURE PUBLISHING GROUP. ISSN 1532-1827